Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies

被引:100
作者
Sullivan, P
Stephens, D
Ansari, T
Costello, J
Jeffery, P
机构
[1] NHLI, Imperail Coll, Sch Med, Lung Pathol Unit,Asthma & Allergy Res Grp, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England
[3] Univ London Kings Coll Hosp, Sch Med, Sackler Inst Pulm Pharmacol, Dept Resp Med, London SE5 8RX, England
关键词
asthma; biopsy; bronchoscopy; chronic obstructive pulmonary disease; variance;
D O I
10.1183/09031936.98.12040811
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We do not have an estimate of how much tissue is needed for a reliable measure of bronchial epithelial reticular basement membrane (RBM) thickness or for counts of inflammatory cells. An assessment of the frequency distribution and variance of data from repeat measurements of RBM thickness and biopsy section inflammatory cell counts in cases with asthma (n=6), chronic obstructive pulmonary disease (COPD; n=5), and normal healthy subjects (n=7) was made. Tissue sections were stained with haematoxylin and eosin or by immunohistochemistry for EG2, mast cell tryptase and CD3-positive cells. Measurements of RBM thickness in individuals followed a log-normal distribution. For a precision of approximately +/-15%,31-45 measurements were required, In contrast, inflammatory cell counts for each individual did not follow a normal distribution, There was high variance such that the cumulative weighted mean did not become stable until at least 5-10 mm of tissue underlying the RBM had been included. In conclusion multiple measurements of reticular basement membrane thickness or tissue section cell counts should be made for each individual in studies of bronchial biopsies, It is recommended that reticular basement membrane thickness should be measured at 20 mm intervals over a 1 mm reticular basement membrane length and that a zone beneath it of at least 5-10 mm of reticular basement membrane should be included for counts of inflammatory cells.
引用
收藏
页码:811 / 815
页数:5
相关论文
共 30 条
[1]  
AITKEN M, 1990, STAT MODELLING GLIM
[2]   LYMPHOCYTES-T AND ACTIVATED EOSINOPHILS IN AIRWAY MUCOSA IN FATAL ASTHMA AND CYSTIC-FIBROSIS [J].
AZZAWI, M ;
JOHNSTON, PW ;
MAJUMDAR, S ;
KAY, AB ;
JEFFERY, PK .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (06) :1477-1482
[3]  
AZZAWI M, 1990, American Review of Respiratory Disease, V141, pA500
[4]   IDENTIFICATION OF ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN BRONCHIAL BIOPSIES IN STABLE ATOPIC ASTHMA [J].
AZZAWI, M ;
BRADLEY, B ;
JEFFERY, PK ;
FREW, AJ ;
WARDLAW, AJ ;
KNOWLES, G ;
ASSOUFI, B ;
COLLINS, JV ;
DURHAM, S ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (06) :1407-1413
[5]   CELLULAR EVENTS IN THE BRONCHI IN MILD ASTHMA AND AFTER BRONCHIAL PROVOCATION [J].
BEASLEY, R ;
ROCHE, WR ;
ROBERTS, JA ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (03) :806-817
[6]   INTERLEUKIN-4, INTERLEUKIN-5, AND INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA IN NORMAL AND ASTHMATIC AIRWAYS - EVIDENCE FOR THE HUMAN MAST-CELL AS A SOURCE OF THESE CYTOKINES [J].
BRADDING, P ;
ROBERTS, JA ;
BRITTEN, KM ;
MONTEFORT, S ;
DJUKANOVIC, R ;
MUELLER, R ;
HEUSSER, CH ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (05) :471-480
[7]   EOSINOPHILS, T-LYMPHOCYTES, MAST-CELLS, NEUTROPHILS, AND MACROPHAGES IN BRONCHIAL BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITH ASTHMA - COMPARISON WITH BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITHOUT ASTHMA AND NORMAL CONTROL SUBJECTS AND RELATIONSHIP TO BRONCHIAL HYPERRESPONSIVENESS [J].
BRADLEY, BL ;
AZZAWI, M ;
JACOBSON, M ;
ASSOUFI, B ;
COLLINS, JV ;
IRANI, AMA ;
SCHWARTZ, LB ;
DURHAM, SR ;
JEFFERY, PK ;
KAY, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :661-674
[8]   MYOFIBROBLASTS AND SUBEPITHELIAL FIBROSIS IN BRONCHIAL-ASTHMA [J].
BREWSTER, CEP ;
HOWARTH, PH ;
DJUKANOVIC, R ;
WILSON, J ;
HOLGATE, ST ;
ROCHE, WR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (05) :507-511
[9]   Corticosteroid reversibility in COPD is related to features of asthma [J].
Chanez, P ;
Vignola, AM ;
OShaugnessy, T ;
Enander, I ;
Li, DC ;
Jeffery, PK ;
Bousquet, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (05) :1529-1534
[10]  
Cockcroft DW, 1985, MEASURE AIRWAY RESPO, P22